| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |